Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Harris Spiridonidis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Hematology (Amsterdam, Netherlands)|August 13, 2003
Evaluating the effectiveness of epoetin alfa in community oncology practicesC Harris Spiridonidis, K Brinkmannb, M Fridman, et al.
Cancer Investigation|October 21, 2004
Phase I study of Doxil and vinorelbine in patients with advanced malignanciesLeslie R Laufman, C Harris Spiridonidis, Jacqueline J Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718Paul J Hesketh, Kari Chansky, Valerie Israel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501William S Velasquez, Danika Lew, Thomas M Grogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349)Douglas W Blayney, Michael L LeBlanc, Thomas Grogan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Hematology (Amsterdam, Netherlands)|August 13, 2003
Evaluating the effectiveness of epoetin alfa in community oncology practicesC Harris Spiridonidis, K Brinkmannb, M Fridman, et al.
Cancer Investigation|October 21, 2004
Phase I study of Doxil and vinorelbine in patients with advanced malignanciesLeslie R Laufman, C Harris Spiridonidis, Jacqueline J Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718Paul J Hesketh, Kari Chansky, Valerie Israel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501William S Velasquez, Danika Lew, Thomas M Grogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349)Douglas W Blayney, Michael L LeBlanc, Thomas Grogan, et al.
Pageof 1